share_log

天宇股份(300702.SZ):诺得药业的沙库巴曲缬沙坦钠片获得批准

Tianyu Co., Ltd. (300702.SZ): Nuode Pharmaceuticals' sacubatrivalsartan sodium tablets approved

Gelonghui Finance ·  Apr 30 04:54

Gelonghui, April 30 | Tianyu Co., Ltd. (300702.SZ) announced that Zhejiang Nuode Pharmaceutical Co., Ltd. (“Nuode Pharmaceutical”), a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for sacubatol valsartan tablets approved and issued by the State Drug Administration. Sacubatl valsartan sodium tablets are drugs for chronic heart failure, used in adult patients with chronic heart failure with reduced ejection fraction and for the treatment of essential hypertension.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment